Halozyme Therapeutics (HALO) Amortizatization of Intangibles (2013 - 2026)

Halozyme Therapeutics (HALO) has 14 years of Amortizatization of Intangibles data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 21.61% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 10.08% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 55.16% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.2 million, up from $96000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for HALO reached as high as $2.4 million in Q1 2024 and fell as low as -$121000.0 in Q4 2022.
• Historically, Amortizatization of Intangibles has averaged $1.1 million across 5 years, with a median of $917000.0 in 2023.
• Across the five-year window, Amortizatization of Intangibles soared 926.98% in 2022 and sank 94.79% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at -$121000.0 in 2022, then jumped by 796.69% to $843000.0 in 2023, then surged by 118.74% to $1.8 million in 2024, then sank by 94.79% to $96000.0 in 2025, then soared by 2238.54% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $2.2 million in Q1 2026, $96000.0 in Q4 2025, and $1.7 million in Q3 2025.